Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1987-6-9
pubmed:abstractText
GM2, GD2, and GD3 gangliosides are expressed on the surface of human melanoma cells and represent potential targets for immunological control of melanoma growth by monoclonal antibodies and active immunization. The immunogenicity of GM2 was investigated by analyzing the humoral immune response of melanoma patients to vaccination with cell lines selected for high GM2 expression and with vaccines containing purified GM2. The whole-cell vaccine and vaccines containing purified GM2 and bacillus Calmette-Guérin (BCG) elicited GM2 antibody in a high proportion of patients, particularly in GM2/BCG-vaccinated patients pretreated with cyclophosphamide and given a GM2/BCG booster immunization. Vaccines containing purified GM2 and Salmonella minnesota R595 as the adjuvant were also effective, but only in patients pretreated with cyclophosphamide. GM2 antibodies in vaccinated patients were of the IgM class and were cytotoxic for GM2-positive targets in the presence of human complement.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-14174000, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-2580625, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-2981601, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-3031684, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-3084502, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-3731079, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-3805726, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-3997282, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-4008930, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-4052966, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-478690, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-4944989, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-6193515, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-6237165, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-6296843, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-6385004, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-6610177, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-6631013, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-6852975, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-6864164, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-6934537, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-7004632, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-7061953, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-7093959, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-7097284, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-7130176, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-7141736, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-7175442, http://linkedlifedata.com/resource/pubmed/commentcorrection/3472242-7381512
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2911-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't